NCT00364065

Brief Summary

The purpose of this study is to see if the Ferris PainWrap is effective in the treatment of chronic low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_4 low-back-pain

Timeline
Completed

Started Sep 2006

Shorter than P25 for phase_4 low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 15, 2006

Completed
17 days until next milestone

Study Start

First participant enrolled

September 1, 2006

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2007

Completed
Last Updated

April 18, 2007

Status Verified

April 1, 2007

First QC Date

August 14, 2006

Last Update Submit

April 17, 2007

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numerical pain rating scale

Secondary Outcomes (7)

  • Pain pressure threshold as determined by the Fischer algometer

  • Number of tender regions, taut bands, reproduction of usual and referred pain, recorded as present or absent

  • Range of motion as measured by inclinometer

  • Roland Morris Back Pain Disability score

  • Short Form-36 score

  • +2 more secondary outcomes

Interventions

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speakers, necessary to understand the protocol and communicate observations to the investigators
  • Low back pain of 3 months or longer. Acceptable conditions include non-specific low back pain or pain associated with lumbar spondylosis without neurological impairment associated with the stenosis.
  • Numerical Pain Rating Scale value of 4.5 or higher, estimated for the past week where 0=no pain and 10=worst possible pain.
  • Pain must interfere in some way with daily activities, assessed by Roland and Morris Disability Survey.
  • Beck Depression Inventory score of 20 or less.
  • Physical examination findings of tenderness, muscle spasm or taut bands, or myofascial trigger points in the low back region. The low back region is defined as the lumbosacral region, below the 12th thoracic vertebra down to the sacro-coccygeal junction, and extending laterally to the plane of the lumbar vertebral transverse processes.

You may not qualify if:

  • Pregnancy
  • NPR rating score of less than 4.5.
  • Neurologic impairment in the legs (absent knee or ankle deep tendon reflexes, dermatome sensory loss or weakness) that indicates lumbar radiculopathy.
  • Presence of cancer (previous diagnosis of cancer, or treated cancer with no sign of recurrence for 5 years is acceptable).
  • Presence of systemic disease that can cause low back pain (endometriosis, prostatitis, chronic renal disease, recurrent urinary tract infections, or other acute infections, not including simple upper respiratory infections without significant coughing).
  • Pending litigation involving back injury.
  • Back related disability.
  • Lumbar laminectomy.
  • Subjects cannot have participated in other research studies within 3 months of starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pain and Rehabilitation Medicine

Bethesda, Maryland, 20814, United States

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Robert D Gerwin, MD

    Assistant Professor, Johns Hopkins School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 14, 2006

First Posted

August 15, 2006

Study Start

September 1, 2006

Study Completion

April 1, 2007

Last Updated

April 18, 2007

Record last verified: 2007-04

Locations